Pharmacists in Glencoe, MN Accepting Medicare
3 Pharmacists found. Showing 1 - 3
 Ms. Kelly Jo Higgins, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2211 11th St. E., Glencoe, MN 55336 Phone: 320-864-5192 Fax: 320-864-2767 |
Alyssa Boesche, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 1805 Hennepin Ave N, Glencoe, MN 55336 Phone: 320-864-3121 |
 Matthew Kelly Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3225 10th St E, Glencoe, MN 55336 Phone: 320-864-5026 |
News Archive
Macaques show low neutralizing antibody and cellular immune response to SARS-CoV-2
A new study published on the preprint server bioRxiv* in August 2020 presents a cynomolgus macaque model that develops symptomatic SARS-CoV-2 infection in a mild form, with low or no antibody responses, making it suitable to study human responses to vaccines and drugs targeting the virus.
Early maternal support boosts robust brain growth in kids
Children whose mothers were nurturing during the preschool years, as opposed to later in childhood, have more robust growth in brain structures associated with learning, memory and stress response than children with less supportive moms, according to research at Washington University School of Medicine in St. Louis.
Integrating HIV prevention and care in Africa
On April 15, 2005 the UCLA AIDS Institute will host a full day symposium on AIDS in Africa entitled Integrating HIV Prevention and Care in Africa: Existing Challenges and Innovative Solutions.
Federal panel awards almost $500 million to La. to replace New Orleans Charity Hospital
Ending one of the longest-running disputes left by Hurricane Katrina, a federal arbitration panel ruled Wednesday that Louisiana would receive $474.8 million — nearly all it had requested — to pay for the replacement of Charity Hospital in New Orleans, which has been closed since the storm.
Cascade Chemistry selected to help speed clinical testing of promising investigational drug for COVID-19
Cascade Chemistry, a leading contract research and manufacturing organization serving the pharmaceutical, materials, and chemical industries, today announced that it has been selected to produce the active pharmaceutical ingredient for clinical trial supplies of RBT-9, an investigational therapy entering a Phase 2 trial for the treatment of COVID-19 patients who are at high risk of deteriorating health due to age or comorbid conditions such as kidney or cardiovascular disease.
› Verified 1 days ago
Dentists
Pharmacists
Marriage Counselors
Counselors
Psychologists
Occupational Therapists